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Conclusion Findings demonstrate that the SPV produces 
higher V˙O2max, peak Q and SV values in the young group. 
However, older participants achieved similar V˙O2max 
values in both protocols, mostly likely due to age-related 
differences in cardiovascular responses to incremental 
exercise, despite them achieving a higher physiological 
workload in the SPV.
Keywords RPE · Maximal exercise · Cardiac output · 
Pacing
Abbreviations
V˙O2max  Maximal oxygen update
SPV  Self-paced V˙O2max test
RPE  Ratings of perceived exertion
HR  Heart rate
VE  Minute ventilation
Q  Cardiac output
SV  Stroke volume
PO  Power output
AT  Anaerobic threshold
RER  Respiratory exchange ratio
DeoxyHb  Muscle deoxyhaemoglobin
NIRS  Near-infrared spectroscopy
VL  Vastus lateralis
EMG  Electromyography
%TTE  Percentage of time to exhaustion
MIVC  Maximal isometric voluntary contraction
Introduction
A self-paced maximal oxygen uptake (V˙O2max) test (SPV) 
allows participants to regulate their own exercise intensity 
according to specific Ratings of Perceived Exertion (RPE), 
Abstract 
Purpose A self-paced maximal exercise protocol has dem-
onstrated higher V˙O2max values when compared against 
traditional tests. The aim was to compare physiologi-
cal responses to this self-paced V˙O2max protocol (SPV) 
in comparison to a traditional ramp V˙O2max (RAMP) 
protocol in young (18–30 years) and old (50–75 years) 
participants.
Methods Forty-four participants (22 young; 22 old) com-
pleted both protocols in a randomised, counter-balanced, 
crossover design. The SPV included 5 × 2 min stages, par-
ticipants were able to self-regulate their power output (PO) 
by using incremental ‘clamps’ in ratings of perceived exer-
tion. The RAMP consisted of either 15 or 20 W min−1.
Results Expired gases, cardiac output (Q), stroke volume 
(SV), muscular deoxyhaemoglobin (deoxyHb) and elec-
tromyography (EMG) at the vastus lateralis were recorded 
throughout. Results demonstrated significantly higher 
V˙O2max in the SPV (49.68 ± 10.26 ml kg
−1 min−1) vs. 
the RAMP (47.70 ± 9.98 ml kg−1 min−1) in the young, but 
not in the old group (>0.05). Q and SV were significantly 
higher in the SPV vs. the RAMP in the young (<0.05) but 
not in the old group (>0.05). No differences seen in deox-
yHb and EMG for either age groups (>0.05). Peak PO was 
significantly higher in the SPV vs. the RAMP in both age 
groups (<0.05).
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which follows an incremental format over 5 × 2 min stages 
(11–20 RPE). The SPV has been shown to allow young 
participants to achieve a higher V˙O2max when compared 
to a standard incremental exercise test in both cycling and 
running exercise modes (Astorino et al. 2015; Mauger and 
Sculthorpe 2012; Mauger et al. 2013), although a mecha-
nistic explanation is yet to be identified. However, not all 
studies have found differences in V˙O2max when comparing 
the SPV vs. standard incremental exercise protocols (Chid-
nok et al. 2013; Faulkner et al. 2015; Straub et al. 2014).
Maximal oxygen consumption is suggested to be limited 
by factors such as: pulmonary diffusion capacity, maximal 
cardiac output, oxygen carrying capacity of the blood, or 
skeletal muscle characteristics (Basset and Howley 2000). 
Mauger et al. (2013) suggested that a higher V˙O2max 
may be achieved during an SPV protocol due to changes 
in oxygen extraction at the working muscles, rather than 
any increase in oxygen delivery. The authors based this 
hypothesis on the observation that participants achieved a 
lower peak heart rate (HR) in the SPV without differences 
in peak minute ventilation (VE); they suggested that if the 
higher V˙O2max were a result of an increase in the oxygen 
delivery it would be expected that both HR and VE would 
be increased (Mauger and Sculthorpe 2012; Mauger et al. 
2013). However, it is possible that increases in stroke vol-
ume (SV), which was not measured by Mauger and Scult-
horpe (2012) and Mauger et al. (2013), may have compen-
sated for the lower HR achieved resulting in an increase 
in oxygen delivery, and thus V˙O2max (Basset and How-
ley 2000). Nevertheless an increased oxygen extraction in 
the SPV may still arise from the participant being able to 
adjust work rate, potentially creating optimal conditions 
that allow enhanced rates of muscle oxygen extraction and 
higher work rates to be achieved. Indeed, previous research 
demonstrates that muscle blood flow, and thus oxygen 
extraction, is reduced when both muscle force and dura-
tion of contractions increase (Bjorklund et al. 2010; Hoelt-
ing et al. 2001). Research has also suggested that decreased 
blood transit time is associated with reduced rates of oxy-
gen extraction (Basset and Howley 2000; Kalliokoski 
et al. 2001). In traditional incremental tests, the continu-
ous increase in force requirement and consistent duration 
of each contraction cannot be adjusted. As a consequence 
this may result in a constriction of the amount of blood 
flow available to the muscle, and reduced time for extrac-
tion to take place. Both force and duration of muscle con-
tractions are free for the participant to vary during the SPV, 
potentially optimising working muscle blood flow. In addi-
tion, it has been suggested that the self-regulation of work 
rate during the SPV may improve the efficiency of muscle 
recruitment, i.e. affording greater reliance on more oxygen 
efficient muscle fibres (Type I), particularly in the earlier 
stages of the test (Mauger and Sculthorpe 2012; Mauger 
et al. 2013). This self-regulation may help to conserve Type 
II fibres for the “all-out” final stage of the SPV protocol 
(RPE 20) which ultimately allows the high work rates to be 
achieved.
A recent study has demonstrated that the SPV may elicit 
a greater cardiac output (Q) and peak HR when compared 
to a standard incremental ramp protocol (Astorino et al. 
2015). The study by Astorino et al. (2015) was the first 
to assess Q across the SPV, and suggests that the greater 
V˙O2max may be explained by an increase in oxygen deliv-
ery (Mortensen et al. 2005), rather than an increase in the 
oxygen extraction as previously suggested. Astorino and 
colleagues (2015) suggested the increase in Q during the 
SPV protocol is likely the result of participants adequately 
pacing their effort to minimise fatigue in the early stages of 
the test. Ultimately, this better pacing led to a greater work 
rate being achieved in the final stage of the SPV, potentially 
because participants preserved the use of type II fibres in 
the earlier stages, resulting in a greater HR, Q and V˙O2max .
It is well accepted that there is a decline in V˙O2max 
with aging, which is predominantly the result of reduc-
tions in maximal Q and muscle blood flow (Betik and Hep-
ple 2008). Cardiac function (Lakatta and Levy 2003), lung 
performance (Chaunchaiyakul et al. 2004; Janssens et al. 
1999) and muscle oxidative capacity (Betik and Hepple 
2008; Russ and Kent-Braun 2004) have all been shown to 
reduce with age, which also contribute to the deterioration 
in V˙O2max. Therefore, the factors limiting factors V˙O2max 
may differ between young and old populations. Conse-
quently, selecting a V˙O2max test protocol which adequately 
stresses the body’s physiological systems is an important 
decision when testing young and older populations. With the 
study of Astorino et al. (2015) demonstrating that the SPV 
protocol produces higher Q and V˙O2max values compared 
to traditional methods, it could be speculated that a self-
paced exercise test provides the best method to maximally 
stress the cardiorespiratory system. Furthermore, examin-
ing cardiopulmonary and muscular responses of young and 
old populations to both SPV and traditional test protocols 
may help explain why higher V˙O2max values are often seen 
from the SPV. Therefore, the aim of the current study was 
to assess physiological responses to both SPV and standard 
incremental ramp test (RAMP) protocols in healthy younger 
(18–30) and older (50–75) populations, and to objectively 
test whether responses differ between the two groups.
Methods
Ethical approval
The study was conducted following institutional ethical 
approval in accordance with the Declaration of Helsinki 
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(2013). All participants who volunteered gave their written 
informed consent.
Participants
Forty-four healthy male and female participants, compris-
ing of twenty-two 18–30-year-olds (age 25 ± 4 years; 
height 174 ± 11 cm; weight 69 ± 9 kg) and twenty-two 
50–75-year-olds (age 59 ± 6 years; height 171 ± 8 cm; 
weight 73 ± 13 kg), volunteered to take part in the current 
study. All participants were apparently healthy, free of dis-
ease, free of any risk factors associated with cardiovascular 
disease and were all physically active (>90 min of moder-
ate activity per week). This information was obtained via 
a health questionnaire. For the older population a resting 
blood pressure measurement was taken on their first visit to 
ensure they were not hypertensive.
Experimental procedure
Each participant visited the laboratory on two separate 
occasions, where they were asked to complete either an 
SPV, or a traditional ramp V˙O2max (RAMP) test using a 
randomised, counter-balanced, and crossover design. Tests 
were separated by at least 24 h to allow full recovery and 
were completed at the same time of the day (±2 h). Par-
ticipants were asked to refrain from drinking alcohol (24 h 
abstinence), eating (2 h abstinence), and not to perform 
any exercise in the 24 h prior to each test. Prior to each 
test participants were required to complete a 5 min warm-
up at approximately 50 W. In the SPV condition during the 
warm-up, participants were familiarised with the process of 
freely adjusting their power output (PO).
SPV protocol
The SPV was completed on an air-braked cycle ergometer 
(Wattbike Ltd, Nottingham, UK), which allowed partici-
pants to continually vary their PO throughout the test. The 
SPV was conducted in accordance with the procedures pre-
viously outlined by Mauger and Sculthorpe (2012). Recent 
data have demonstrated good test–retest reliability of both 
maximal and submaximal physiological data obtained 
from the SPV protocol in both young healthy, and older 
clinical populations (Jenkins et al. 2016). Briefly, the SPV 
consisted of 5 × 2-min stages (total test time of 10-min), 
where for each stage participants were able to continuously 
vary their PO, but with RPE (Borg 1998; 6–20 scale) fixed 
at a particular rating for each stage (RPE 11, 13, 15, 17 
and 20), following an incremental format. Changes in PO 
were facilitated by the participants manually adjusting the 
cycle ergometer air brake and cadence in order to produce 
a work rate that allowed them to match the target RPE for 
each stage of the SPV. Participants were able to view their 
cadence and PO throughout the test; they also received 
feedback on elapsed time particularly when approaching 
the end of a stage.
RAMP protocol
The traditional V˙O2max protocol was completed on an 
electro-magnetically braked cycle ergometer (Corival, 
Lode, Groningen, Netherlands) so that PO was fixed for 
each stage of the incremental RAMP protocol. The cycle 
ergometer was set in hyperbolic mode to ensure that any 
changes in cadence did not influence PO. Participants were 
instructed to keep their cadence above 60 rev min−1. The 
RAMP commenced with a 3 min period of baseline cycling 
where a various range of work rate starting points were 
selected for each participant (20, 50 and 100 W), according 
to self-reported fitness levels. This 3 min period was then 
followed by RAMP increments of either 15 or 20 W min−1. 
The starting point and the rate of increase in work rate was 
individualised in the attempt to optimise the protocol for 
each participant. The test was terminated when the par-
ticipant could no longer continue, or if they were unable 




During both exercise tests, expired gases were measured 
via the use of an online breath-by-breath analysis system 
(Cortex Metalyzer 3BR2, Cortex, Leipzig, Germany). After 
each test, V˙O2max was calculated as the highest 30 s aver-
age V˙O2 (l min
−1 and ml kg−1 min−1). Peak cycling PO and 
minute ventilation (V˙E) were also both calculated as the 
highest 30 s average value. The anaerobic threshold (AT) 
was determined using the V-slope method with confirma-
tion via the ventilatory equivalents (V˙E/V˙O2 and V˙E/V˙CO2 ) 
and the partial end-tidal (PETO2 and PETCO2) methods 
(Hopker et al. 2011). All AT’s were independently assessed 
by two experienced researchers. If the two researchers 
disagreed on the location of the AT, a third researcher was 
consulted.
NIRS
Muscle deoxyhaemoglobin (deoxyHb) was measured using 
a Near-Infrared Spectroscopy (NIRS) device (Portamon, 
Artinis Medical Systems, Elst, Netherlands). The device 
uses small skin surface lasers to measure light absorb-
ance, operating at wavelengths between 760 and 850 nm, 
with an average optode distance of 35 mm and a sampling 
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rate of 10 Hz. The device was placed longitudinally on the 
vastus lateralis (VL) of the left leg, and was situated 10 cm 
above the patella (Wang et al. 2012). Before placement of 
the NIRS device, the NIRS system was calibrated and the 
skin was carefully shaved. The device was secured to the 
site using adhesive tape, which covered the whole device 
to reduce light loss. Afterwards, the deoxyHb was exported 
into 1 s values and then averaged into 30 s at 10 time points 
over both tests. A baseline deoxyHb from the NIRS was 
averaged from the final 30 s of the first stage, and the peak 
was determined from the average of the final 15 s of each 
test. The deoxyHb for each time point was then normalized 
to the total amplitude of response (peak − baseline) (Boone 
et al. 2010). This was then plotted as a function of percent-
age of time to exhaustion (%TTE).
Electromyography (EMG)
Surface EMG was recorded using a wireless Biopac MP150 
(Biopac Systems Inc, CA, USA), two surface electrodes 
were placed on the VL of the right leg and a reference elec-
trode was placed on the patella of the same leg. The skin 
was prepared by carefully shaving and cleaning the area. 
EMG was recorded at a sampling frequency of 1000 Hz. 
Prior to each V˙O2max test, participants performed three 
maximal isometric voluntary contractions (MIVC) of the 
VL muscle in order to determine the peak EMG signal 
during a maximal muscle contraction. The MIVCs were 
completed on a Cybex Isokinetic Dynamometer (HUMAC 
Norm, CSMi, Stoughton, MA, USA). Before the MIVCs 
a series of submaximal contractions were completed as a 
preparatory warm-up. Each MIVC lasted 5 s, with 1 min 
rest between each. Participants were also required to com-
plete one MIVC directly after both V˙O2max tests to deter-
mine the level of muscle fatigue, this occurred 1 min after 
the test or as close to 1 min as possible; depending on how 
quickly the participant was safely able to move off the bike 
and onto the dynamometer. Maximum EMG was calculated 
by averaging the highest 1 s EMG value from each MIVC 
trial. The 30 s average EMG signals from each stage of 
the SPV and RAMP was then normalized to the maximum 
EMG from the MIVC. Data were plotted as a function of 
%TTE from each V˙O2max test. It was decided to include 
the whole 30 s of the EMG signal within the average, thus 
the inactive periods were included. The authors are aware 
that including the inactive periods between each contrac-
tion may been seen as a limitation as variations in cadence 
would influence the average of EMG (e.g. higher cadence 
would results in a higher EMG average). However, given 
the nature of the current study it was felt that excluding the 
inactive periods would not be necessary in order to provide 
an estimate of the overall muscle activity during each stage 
of the SPV or RAMP test.
Cardiac output and stroke volume
A non-invasive thoracic impedance device (PhysioFlow, 
Manatec Biomedical, France) was used to measure stoke 
volume (SV) and Q throughout the duration of both 
V˙O2max tests. Electrodes were positioned in the follow-
ing areas; above the supraclavicular fossa (participants’ left 
side), xiphoid process and two additional electrodes were 
placed to determine a single ECG signal at V1 and V6 posi-
tions. Prior to electrode placement, all skin sites were care-
fully cleaned, and shaved where necessary. In accordance 
with the manufacturer recommendations, the equipment 
was auto-calibrated prior to each test by establishing imped-
ance waveforms over 30 heart beats. Peak Q and SV were 
determined by the highest 30 s average value over the entire 
duration of the test. A 30 s average of SV and Q was plot-
ted, for every 2 min, as a function of percentage of time to 
exhaustion (%TTE) from each V˙O2max test. Arteriovenous 
oxygen difference (a-vO2diff) was calculated as V˙O2max 
(ml min−1)/Q (l min−1), and expressed in ml 100 ml−1. The 
Q value was taken as the value at V˙O2max, rather than peak 
Q achieved during the incremental test protocol.
Blood lactate
A finger-tip capillary blood sample was taken directly at 
the end of each V˙O2max test to determine end-exercise 
blood lactate concentrations (Biosen C-Line, EKF Diag-
nostic, London, UK).
Statistical analysis
All statistical analysis was conducted using SPSS (SPSS, 
Chicago, IL, USA) with significance levels accepted at 95% 
(p < 0.05). All data were checked for normality using the 
Shapiro–Wilk test and Q–Q plots. The mean maximum val-
ues for V˙O2max, AT, PO, HR, V˙E, blood lactate, Q and SV 
were all compared between the protocols using a paired sam-
ple t test. The percentage difference between the pre-MIVC 
and post-MIVC (highest 1 s EMG and torque) from the SPV 
and RAMP was also compared using a paired sample t test. 
Differences (p < 0.05) between Q, SV, deoxyHb and EMG 
for the last 30 s of each stage, in both the SPV and RAMP 
tests were assessed using a repeated measures ANOVA 
(2 × 10 for NIRS and EMG; 2 × 6 for Q and SV). Violations 
of the assumptions were assessed using the Mauchly’s test of 
sphericity, if p was >0.05 then sphericity was assumed but 
if p was <0.05 then Greenhouse–Geisser corrections were 
used. If an interaction was present then Bonferroni post hoc 
testing was used to identify where the interaction occurred. 
The two defined groups, young (18–30 years) and old (50–
75 years), were analysed separately. All data are presented as 
mean ± SD unless otherwise stated.
Eur J Appl Physiol 
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Results
Table 1 presents data from the physiological parameters 
measured during the two tests for both young and old 
individuals. In the younger population there was a signifi-
cantly higher V˙O2max (l min
−1 and ml kg−1 min−1), peak 
V˙E, peak RER, peak Q, peak SV and peak PO achieved in 
the SPV compared to the RAMP protocol (p < 0.05). The 
a-vO2diff was significantly lower in the SPV compared to 
the RAMP (p < 0.05). There were no differences in AT, 
peak HR, end-exercise lactate and TTE (p > 0.05). Sig-
nificant differences in peak RER, peak PO and TTE were 
found between protocols in the older population (p < 0.05). 
Figure 1 shows the V˙O2 response over time from a repre-
sentative participant of each group in both SPV and RAMP 
protocols. Participants were selected as they were repre-
sentative of both mean V˙O2max values, and average differ-
ences between the two test protocols.
NIRS
Prior to analysis, data from three participants in the 
young, and six in the older group were excluded due to a 
poor quality NIRS signal. There was no interaction effect 
between test protocol and the increase in deoxyHb over 
time (p > 0.05). Figure 2 illustrates the relative change in 
deoxyHb over the duration of RAMP and SPV protocols, 
in the both young and old groups. A main effect of time 
was evident as deoxyHb increased significantly during 
both test protocols in both age groups (p < 0.01). Specifi-
cally, data demonstrated that in the young group, deoxyHb 
in the RAMP significantly increased up to 70% of TTE 
(p < 0.05); in the SPV there were differences between 
30–40, 40–50, and 60–70% of TTE (p < 005). For the 
old group in the RAMP there were differences between 
20–30, 30–40, and 40–50% of TTE (p < 0.05); in the SPV 
there were differences between 30–40, 40–50, 50–60, and 
60–70% of TTE (p < 0.05).
EMG
There was no interaction effect evident between the 
increase of relative EMG between the protocols in the 
young group. However, in the old population an interaction 
effect was evident, with post hoc testing demonstrating a 
significantly higher EMG at 70% of TTE in the SPV com-
pared to the RAMP (p < 0.05). There was a main effect of 
time in both age groups as the relative EMG increased sig-
nificantly in relation to %TTE (p < 0.01; Fig. 3). Post hoc 
analysis demonstrated that for the young group, there was 
a significant difference between 80 and 90% of TTE for 
the RAMP, and between 20 and 30% TTE for the SPV. For 
the old group, post hoc analysis demonstrated a significant 
difference between 90 and 100% of TTE from the RAMP, 
with no significant differences between the successive 
stages in the SPV. There were no differences in the per-
centage of change from pre- to post-MIVC EMG or torque 
between the SPV and RAMP (p > 0.05).
Cardiac Output and Stroke Volume
Prior to analysis, data from five participants in the old 
group (total n = 17) and four from the young group (total 
n = 18) were excluded due to a poor quality signal. Fig-
ure 4 presents the mean and SD for Q, SV, V˙O2 and HR 
as a time series plot. Only those participants with complete 
Table 1  Measured physiological variables recorded during SPV and RAMP V˙O2max tests for both young and old populations
* Significantly different from the ramp (<0.05). Data are presented as mean ± SD
Young (18–30 years) Older (50–75 years)
Ramp SPV p value Ramp SPV p value
V˙O2max (l min
−1) 3.34 ± 0.88 3.45 ± 0.87* 0.02 2.74 ± 0.76 2.78 ± 0.74 0.79
V˙O2max (ml kg
−1 min−1) 47.70 ± 9.98 49.68 ± 10.26* <0.01 38.99 ± 9.54 39.12 ± 8.61 0.84
AT (ml kg−1 min−1) 25.36 ± 6.71 24.55 ± 5.18 0.32 21.69 ± 6.17 22.34 ± 6.36 0.23
HR (bpm) 181 ± 10 183 ± 9 0.19 164 ± 12 164 ± 12 0.93
V˙E (l min−1) 130.7 ± 32.9 147.7 ± 37.4* <0.01 122.8 ± 31.4 129.4 ± 29.6 0.08
RER 1.24 ± 0.05 1.31 ± 0.08* <0.01 1.22 ± 0.09 1.32 ± 0.12* <0.01
Peak Q (l/min−1) 23.4 ± 5.9 27.3 ± 3.8* 0.01 24.1 ± 5.0 25.8 ± 5.1 0.24
Peak SV (ml) 134.6 ± 37.5 160.0 ± 27.8* <0.01 156.9 ± 29.9 166.8 ± 29.0 0.23
End-exercise lactate (mmol/l) 8.06 ± 1.74 9.52 ± 2.85 0.06 6.15 ± 1.88 7.21 ± 2.89 0.05
Peak PO (W) 265 ± 69 336 ± 122* <0.01 226 ± 63 245 ± 74* <0.01
a-vO2diff (ml 100 ml
−1) 18.1 ± 5.9 15.5 ± 3.9* 0.04 13.3 ± 2.4 13.9 ± 5.4 0.61
TTE (s) 637 ± 153 600 ± 0 0.26 695 ± 149 600 ± 0* <0.01
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data sets were included in this figure, therefore mean values 
for V˙O2max and HR differ to those presented in the Table 1 
where all participants were included. In the young group, 
there was an interaction effect evident between test pro-
tocol and both Q and SV over time. Specifically, post hoc 
testing demonstrated differences in Q between the two tests 
at 6, 7, 8 min as well as the peak value, and SV at 6 min, 
7 min, and the peak values (p < 0.05). There was a main 
effect of time (p < 0.01), for both Q and SV in the young 
group. Post hoc testing identified significant differences in 
Q occurred between baseline and 1 min, 2 min to 5 min, 
and 8 min and peak in the RAMP, and between baseline 
and 1 min, 3 min to 4 min, 5 min to 6 min, 8 min and 
peak in the SPV. Differences in SV were evident between 
baseline and 1 min, and 8 min and peak in the both test pro-
tocols in the young group (p < 0.05). In the old population 
there was a trend for an interaction effect between protocol 
and time for Q (p > 0.07), and a significant interaction for 
SV (p < 0.05). There was main effect for test protocol in 
both Q and SV (p > 0.05). However, there was an overall 
main effect of time for Q and SV (p < 0.01). Post hoc test-
ing demonstrated differences in Q from baseline to 1 min, 
2 min to 5 min, and between 8 min and peak in the RAMP, 
and differences from baseline to 1 min, 2 min to 3 min, and 
4 min to 5 min in the SPV. For SV differences were evident 
from baseline to 1 min, 3 min to 4 min, and 8 min to peak 
in the RAMP, and differences from baseline and 1 min, and 
8 min to peak in the SPV (p < 0.05).
Fig. 1  V˙O2 response over %TTE in the RAMP and SPV in a representative: a young and b old participant
Fig. 2  Relative change in deoxyHb vs. %TTE in the RAMP and SPV for: a young and b old population. *Main effect (p < 0.05). Data are 
mean ± SD
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Power Output Profile
Figure 5 illustrates the mean PO values for each stage of 
the SPV for both the young and old groups.
Discussion
This is the first study to assess both the cardiovascular and 
muscular response to an incremental self-paced exercise 
test compared to a standard RAMP protocol, and do so in 
both young and older populations. In support of previous 
literature (Astorino et al. 2015; Mauger and Sculthorpe 
2012; Mauger et al. 2013), the results of the current study 
demonstrate that younger participants were able to achieve 
a significantly higher V˙O2max in the SPV compared to the 
RAMP protocol. However, this was not evident in the older 
population where there were no differences in V˙O2max 
between the two protocols. The results also demonstrate 
that the SPV produced a higher peak Q and peak SV in the 
young group, which was statistically different between the 
SPV and RAMP at the latter stages of the test. No differ-
ences in these parameters were evident between tests in 
the older group. However, interestingly higher physiologi-
cal work rates were achieved by participants from both age 
groups (as evidenced by the significantly greater peak PO 
and RER values) in the SPV protocol, but this only lead to 
a higher V˙O2max in the young group. In turn this suggests 
that the limiting factor to V˙O2max and the mechanisms 
behind the SPV may differ between young and old popu-
lations. Results from the current study also demonstrate a 
lack of protocol specific patterns of deoxyHb and muscle 
recruitment of the VL, suggesting that oxygen extraction 
was not enhanced by the SPV.
In support of findings of the current study, Astorino et al. 
(2015) demonstrate a significantly higher Q and V˙O2max 
in the SPV when compared against a standard exercise test 
protocol. The authors suggested that the higher Q during 
the SPV is responsible for the higher V˙O2max observed 
due to an increased oxygen delivery to the working mus-
cles. It is well accepted that there is a strong linear relation-
ship between Q and V˙O2, with Q being a principal limit-
ing factor for V˙O2max during whole-body exercise (Basset 
and Howley 2000). Therefore, it would be expected that a 
higher Q would result in a greater V˙O2max being achieved. 
Results from the current study demonstrate a significantly 
higher Q achieved in the SPV vs. the RAMP in the young, 
but not the old population. Interestingly, with V˙O2max only 
being significantly higher in SPV in the young group, it 
suggests that Q might be the primary limiter. However, it 
must be acknowledged that peak values for Q and V˙O2max 
may not have necessarily occurred at the same time in the 
SPV, and so caution must be applied when identifying an 
increased Q as the sole explanation for the higher V˙O2max 
on the basis of these data. Nevertheless, the same maxi-
mal heart rate achieved in both protocols suggests that the 
enhanced Q seen in the young group is predominantly the 
result of the higher SV achieved in the SPV vs. RAMP. 
However, as stated above, this cannot be confirmed as peak 
SV and peak HR may not have necessarily occurred at the 
same time point. Indeed, previous literature has suggested 
that differences in V˙O2max between individuals are primar-
ily a result of the differences in maximal SV, as less inter-
individual variation is seen in maximal HR (Basset and 
Fig. 3  Normalized EMG relative to %TTE over the RAMP and SPV for: a young and b old populations. *Main effect (p < 0.05). Data are 
mean ± SD
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Howley 2000). In traditional V˙O2max tests it is known that 
SV begins to plateau/fall prior to V˙O2max being reached, 
whilst HR continues to increase to a maximal level, thus 
causing a plateau in Q near the end of the exercise test 
(Mortensen et al. 2005). This demonstrates an impairment 
of the circulatory system to continue supplying a linear 
increase in oxygen delivery at higher exercise intensities 
(Mortensen et al. 2005). The main cause for the plateau/
fall in SV is suggested to be predominately attributed to a 
decrease in diastolic filling time as a result of the increas-
ing heart rate (Higginbotham et al. 1986; Vella and Rob-
ergs 2005). From the data presented in Fig. 4 it is evident 
that SV in the young group increases to a greater extent in 
the SPV than in the RAMP. A plateau in SV is also evident 
where the rate of increase from the early stages of the test 
appears to “level-off” sooner in the RAMP than in the SPV. 
As a result, the increase in Q during the final stage of the 
SPV test is greater than in the RAMP protocol. In the older 
group a plateau in SV is evident in both tests, although 
there is a trend for SV to be higher in the latter stages of 
the SPV compared to the RAMP. This, combined with the 
significantly higher HR in minute 7 and 8 during the SPV, 
may partly explain the observed higher Q in the 6th, 7th 
and 8th minute.
As participants are free to make adjustments in work 
rate, it may be that the self-paced nature of the SPV (par-
ticularly in the younger populations), contributes to the 
prevention of an early plateau in SV by potentially creat-
ing more optimal physiological conditions to maintain 
adequate oxygen delivery. However, further research is 
required to test this hypothesis and examine the under-
pinning mechanisms behind the SV response. Despite the 
young group’s higher peak Q, their peak a-vO2diff was 
lower in the SPV, which would have potentially negatively 
affected the magnitude of the observed V˙O2max. Unfortu-
nately, data from the current study cannot identify reasons 
for the observed lower a-vO2diff, but an oxygen diffusion 
limitation (caused by the higher Q), or reductions in muscle 
blood flow may be likely candidates. Future studies using 
invasive, direct measures of a-vO2diff are necessary to 
investigate these proposed mechanisms.
Older participants demonstrated no significant differ-
ences in V˙O2max between the SPV and RAMP protocols. 
It is possible that the effect of the protocol is reduced in 
the older group due to their inability to further increase Q 
in response to the increased work rates that the SPV proto-
col allows (as seen in the young group). Indeed, previous 
research has suggested that Q plateaus at around ~80% of 
peak PO (Mortensen et al. 2005), and even though in the 
young group there were no significant differences in the 
increase of Q between the final time points (6–8 min) of 
the SPV (p > 0.05), the pattern of response is not the same 
as in the RAMP (see Fig. 4). Moreover, even though there 
were no differences in peak Q in the old group between the 
two tests, they still achieved a higher PO in the SPV vs. the 
RAMP. It is not clear why this differential response in Q 
has been observed between age groups across the test pro-
tocols, but it has been suggested that there are age-related 
changes which occur in relation to cardiac function in 
healthy individuals. In particular these changes in cardiac 
function include left ventricular wall thickness, reductions 
in diastolic filling, impaired left ventricular ejection frac-
tion, and reductions in HR (Lakatta and Levy 2003). All 
of these changes are known to influence cardiac function 
(Lakatta and Levy 2003). In particular, reductions in dias-
tolic filling time is suggested to be the primary cause of 
the plateau that occurs in SV above a certain exercise level 
in older individuals (Higginbotham et al. 1986; Vella and 
Robergs 2005; Lakatta and Levy 2003). This could be the 
key reason why the older group did not achieve a higher 
peak Q and therefore V˙O2max during the SPV (as seen in 
the young group). However, interestingly, higher absolute 
peak Q and SV values were found in the older group com-
pared to the young group in both test protocols, which sug-
gests reduced cardiac function was not evident in this older 
population.
A further speculative reason for the divergent protocol 
effects on V˙O2max between the age groups could be due 
to the known age-related changes that occur at the periph-
ery. Research has suggested that there is a reduced muscle 
oxidative capacity in older populations (Betik and Hepple 
2008; Russ and Kent-Braun 2004) due to loss in mitochon-
drial content and function, and a reduction of muscle vol-
ume (Conley et al. 2000). This reduced oxidative capacity 
is likely to affect the a-vO2diff, which according to the 
Fick equation, contributes to the attainment of V˙O2max. 
In support of this speculation, data from this study dem-
onstrate that the a-vO2diff is lower in the old compared 
to the young group. A further possibility is that due to the 
reduced lung performance associated with normal age-
related decline (Chaunchaiyakul et al. 2004; Janssens et al. 
1999), there is an increase in the oxygen cost of breath-
ing meaning that more Q is needed to be directed to the 
lungs to support ventilation during exercise (Proctor et al. 
1998). Indeed, a 20–30% decrease in leg blood flow during 
cycling has been shown in older, compared to younger sub-
jects (Proctor et al. 1998). Thus, age-related reductions in 
Fig. 4  Mean Q, SV, V˙O2 and HR in both SPV and RAMP protocols 
in young (left; a, c, e, g) and old (right; b, d, f, h) groups. Due to 
variations in test time from the RAMP protocol values are presented 
to isotime (8 min), followed by the peak values obtained in each test. 
#Significant main effect of time (p < 0.05). *Significant difference 
between the SPV and RAMP (p < 0.05). Data are mean ± SD
◂
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leg muscle blood flow may have affected oxygen delivery 
to the working muscle and consequently limited a-vO2diff 
and V˙O2max.
Previous literature has shown the SPV to produce higher 
V˙E values when compared to a standard V˙O2max proto-
col in a young population (Astorino et al. 2015; Faulkner 
et al. 2015; Hogg et al. 2014; Mauger et al. 2013). Inter-
estingly, studies that demonstrate no difference in V˙O2max 
between the SPV and standard RAMP protocols also failed 
to find differences in V˙E (Chidnok et al. 2013; Straub et al. 
2014). The greater V˙E demonstrated by younger partici-
pants in the current study, and also reported in previous 
studies (Astorino et al. 2015; Faulkner et al. 2015; Hogg 
et al. 2014; Mauger et al. 2013), is likely due to the “all-
out” effort required during the final stage (RPE 20) of the 
test. End-test lactate values (see Table 1) suggest that this 
“all-out” effort results in a greater level of metabolic stress 
than experienced in standard RAMP testing. The greater 
level of acidosis and metabolic buffering would therefore 
increase the ventilatory response during high intensity 
exercise (Milani et al. 2006). However, Mauger and Scult-
horpe (2012) observed no differences in V˙E between the 
RAMP and SPV protocols even though a higher V˙O2max 
was achieved in the SPV. Therefore, it is still questionable 
whether or not the higher V˙O2max resulting from the SPV 
protocol is a result of a higher rate of V˙E.
Interestingly, in contrast to the current findings, Chidnok 
et al. (2013) did not find a higher V˙O2max, V˙E or end-test 
blood lactate concentration from a SPV protocol compared 
to a standard RAMP test. However, the differences in the 
outcomes between Chidnok et al. and the current study 
could be attributed to the SPV test protocol designs. As 
outlined above, the SPV protocol from the current study 
requires an “all-out” effort to be maintained for the dura-
tion of the final stage. This “all-out” maximal effort is very 
different to pacing a maximal effort (RPE 20) as the high-
est work rate that can be sustained for the duration of the 
stage, as required by the protocol of Chidnok et al. (2013). 
This fundamental difference between the two test protocols 
is the likely reason for the disparity between the findings of 
the two studies. Indeed, data from the current study dem-
onstrate a mean decrease in PO in the final stage of 120 W 
for the young group, and 73 W for the older group. This is 
in contrast to the data from Chidnok’s study which demon-
strate a mean reduction in PO of just 20 W during the final 
stage of their SPV protocol. Thus, it could be suggested 
the final stage “all-out” effort might be required in order 
to drive the mechanisms that pertain to the higher V˙O2max 
in SPV tests using this protocol design. Interestingly, the 
PO values at the point of V˙O2max in the current study were 
significantly higher in the RAMP compared to the SPV in 
both the young (RAMP 263 W; SPV 219 W; p < 0.01), and 
old group (RAMP 222 W; SPV 195 W; p < 0.01). These 
findings suggest that in the SPV, V˙O2max values seem to 
occur when PO is submaximal. Previous research supports 
this finding and has demonstrated that PO can be dissoci-
ated with V˙O2max; i.e. PO does not necessarily have to be 
maximal to achieve maximal V˙O2 values (Billat et al. 2013, 
Milani et al. 2006). Thus, the nature of the “all-out” final 
stage of the SPV test (RPE 20), and time delay in the oxy-
gen uptake kinetic response, is likely to be the reason for 
the dissociation between V˙O2max and the peak PO values.
Limitations
A limitation of the current study is that different cycle ergom-
eters were used to complete the RAMP and SPV. It has 
previously been suggested that different ergometers might 
cause differences in metabolic cost and cardiovascular strain 
(Reiser et al. 2000). Indeed, various factors such as saddle 
angle (Umberger et al. 1998), body positioning (Too 1991) 
and saddle to pedal distance (Too 1993) have been shown 
to influence maximal cycling performance. However, dif-
ferent ergometers were necessary to be able to conduct the 
two protocols as the SPV required participants to freely 
adjust their PO, and the RAMP required accurate fixing of 
PO. Even though different ergometers were used, the cur-
rent study demonstrated similar magnitude of differences in 
V˙O2max between RAMP and SPV as those reported in previ-
ous studies where the same ergometer was used for both tests 
(Astorino et al. 2015, Mauger and Sculthorpe 2012). Chidnok 
et al. (2013) also used different cycle ergometers when mak-
ing comparisons between the SPV and standard RAMP pro-
tocols but found no significant differences in V˙O2max.
The use of non-invasive techniques to estimate Q and 
SV have previously been criticised for their lack or accu-
racy and reliability when compared against more invasive 
Fig. 5  Power output profile from the SPV in the young and old 
groups
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techniques (e.g. direct Fick method), with the typical error 
being reported to be around 9% for peak Q and SV (Wels-
man et al. 2005). There is also the possibility that move-
ment and respiratory artefacts associated with exercise may 
have affected our results (Siebenmann et al. 2015). How-
ever, previous research has demonstrated that non-invasive 
devices such as that used in the current study are a reliable 
and provide clinically acceptable measures of Q and SV in 
adults during exercise (Charloux et al. 2000, Richard et al. 
2001). Nevertheless, the authors accept that caution must 
be applied when drawing conclusions from such measures.
The SPV allows participants to freely adjust both work-
load and cadence. Previous research by Gottshall and col-
leagues (Gottshall et al. 1996) has suggested that large vari-
ations in cadence could influence the muscle blood flow and 
Q response to exercise. Thus any differences in cadence 
between SPV and RAMP protocols may have influenced 
the current results. However, the study by Gottshall et al. 
(1996) was completed during submaximal steady state exer-
cise, and we are unaware of any studies that have presented 
similar data obtained during maximal incremental exercise. 
Therefore, it is difficult to determine whether cadence dif-
ferences were a confounding variable within our study. 
Nevertheless, the mean cadence from both test protocols 
were similar in the young (RAMP 76 rev min−1; SPV 78 
rev min−1), and identical in the old group (77 rev min−1). 
We are therefore confident that cadence is unlikely to have 
had a substantial influence on the results.
Conclusion
In agreement with the findings of previous research, the 
current study demonstrates that the SPV produces higher 
V˙O2max values compared to a standard RAMP based 
protocol in a young healthy population. It is possible that 
the higher V˙O2max in the SPV protocol is the result of 
an increase in the oxygen delivery (increased Q and V˙E), 
rather than a result of any increase or change in the oxy-
gen extraction at a muscular level. However, it is unclear 
if these peak values all occurred at the same time, and 
therefore whether they mechanistically explain the higher 
V˙O2max seen in the SPV protocol. In contrast, no differ-
ences in V˙O2max between the SPV and RAMP protocols 
were seen in the older population, despite greater peak 
RER and PO values being achieved in the SPV. The rea-
sons for the divergent findings between age groups are 
unclear, although age-related changes in the physiological 
response to exercise are a possible explanation. Nonethe-
less, these findings suggest that the SPV protocol enables 
participants achieve work rates that are closer to true physi-
ological maximum, compared to a traditional RAMP proto-
col. Whilst this is manifested as a higher V˙O2max in young 
populations, a similar V˙O2max is observed in older popula-
tions. Therefore, this study demonstrates that the SPV is a 
valid determinant of V˙O2max in both young and old popu-
lations, and provides a more adequate assessment of a par-
ticipant’s maximal aerobic capacity.
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